Jay H. Solanki, Thomas Tritt, Jordan B. Pasternack, Julia J. Kim, Calvin N. Leung, Jason D. Domogauer, Nicholas W. Colangelo, Venkat R. Narra and Roger W. Howell The treatment of cancer using targeted ...
The prevalence of MASLD has decreased, whereas the prevalence of liver fibrosis and cirrhosis have increased among US patients with type 2 diabetes since 2017. The prevalence of liver fibrosis and ...
At 52 weeks, 100% of subjects (n=4) showed over 30% improvement in pain and function. No serious adverse events or dose-limiting toxicity were reported at 26 to 52 weeks. Ready to turn the market’s ...
Hosted on MSN
'Took public comment into consideration': Solar compensation rates decreasing after months of debate
Nearly 14,000 Idaho Power customers with rooftop solar panels will receive about 30% less compensation for excess energy they send back to the electrical grid, following a decision by the Idaho Public ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback